U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07860710) titled 'J-LINX: Japan LINerixibat eXtension Study' on Sept. 30.
Brief Summary: This study evaluates the long-term safety and tolerability of linerixibat in Japanese adults with cholestatic pruritus in primary biliary cholangitis (PBC) who previously participated in the linerixibat long-term safety and efficacy study, LLSAT (NCT04167358). Participants will continue receiving linerixibat while researchers monitor adverse events and other safety measures to better understand the long-term safety of treatment and provide continued access to therapy.
Study Start Date: Oct. 09
Study Type: INTERVENTIONAL
Condition:
Pruritus
Intervention:
DRUG...